gadolinium dtpa has been researched along with fosbretabulin in 7 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (fosbretabulin) | Trials (fosbretabulin) | Recent Studies (post-2010) (fosbretabulin) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 588 | 21 | 310 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beauregard, DA; Brindle, KM; Chaplin, DJ; Hill, SA | 1 |
Beauregard, DA; Brindle, KM; Hill, SA; Pedley, RB | 1 |
Galbraith, SM; Lodge, MA; Maxwell, RJ; Padhani, AR; Rustin, GJ; Sena, L; Stirling, JJ; Taylor, NJ; Tozer, GM; Wilson, J | 1 |
Boesch, C; Bosmans, H; Chen, F; De Keyzer, F; Hermans, R; Landuyt, W; Marchal, G; Ni, Y; Sun, X; Thoeny, HC; Vandecaveye, V; Verbeken, EK | 1 |
Begent, R; Daley, F; Gaya, A; Padhani, A; Pedley, RB; Qureshi, U; Rustin, G; Stirling, JJ; Taylor, NJ; Tozer, G; Wellsted, D | 1 |
Horsman, MR; Maxwell, RJ; Mouridsen, K; Nielsen, T; Stødkilde-Jørgensen, H; Østergaard, L | 1 |
Feng, Y; Gao, M; Huang, D; Jiang, C; Li, Y; Lou, B; Ni, Y; Peng, F; Sun, Z; Yao, N; Zhang, J | 1 |
7 other study(ies) available for gadolinium dtpa and fosbretabulin
Article | Year |
---|---|
The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability.
Topics: Albumins; Animals; Antineoplastic Agents, Phytogenic; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred CBA; Mice, SCID; Neoplasms, Experimental; Neovascularization, Pathologic; Phosphorus; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, SCID; Stilbenes; Transplantation, Heterologous; Xanthenes; Xanthones | 2002 |
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Humans; Infusion Pumps; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Experimental; Rats; Stilbenes; Treatment Outcome | 2003 |
Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.
Topics: Animals; Antineoplastic Agents, Phytogenic; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Image Processing, Computer-Assisted; Injections, Intraperitoneal; Linear Models; Magnetic Resonance Imaging; Male; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Soft Tissue Neoplasms; Stilbenes | 2005 |
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.
Topics: Actins; Adult; Aged; Angiogenic Proteins; Antigens, CD; Antineoplastic Agents, Phytogenic; Endoglin; Endothelium, Vascular; Female; Gadolinium DTPA; Humans; Immunohistochemistry; Integrin beta3; Magnetic Resonance Angiography; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Receptors, Cell Surface; Stilbenes | 2008 |
Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
Topics: Algorithms; Animals; Antineoplastic Agents, Phytogenic; Contrast Media; Female; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Sarcoma, Experimental; Stilbenes | 2008 |
Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model: in vivo magnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mice; Spectrophotometry, Atomic; Stilbenes; Time Factors; Tissue Distribution | 2015 |